| Date Filed | Type | Description |
| 04/29/2021 |
GN
| Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021 |
| 04/06/2021 |
GN
| Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference |
| 03/29/2021 |
GN
| Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection |
| 03/15/2021 |
GN
| Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020 |
| 03/08/2021 |
GN
| Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021 |
| 02/26/2021 |
GN
| Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference |
| 12/29/2020 |
GN
| Amphastar Announces Approval for Glucagon for Injection Kit, 1mg |
| 11/06/2020 |
GN
| Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020 |
| 10/06/2020 |
GN
| Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection |
| 09/03/2020 |
GN
| Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference |
| 07/30/2020 |
GN
| Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020 |
| 06/19/2020 |
GN
| Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference |
| 06/12/2020 |
GN
| Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference |
| 06/09/2020 |
GN
| Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial |
| 06/02/2020 |
GN
| Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference |
| 05/07/2020 |
GN
| Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020 |
| 04/27/2020 |
GN
| Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial |
| 04/13/2020 |
GN
| Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure |
| 04/09/2020 |
GN
| Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference |
| 03/05/2020 |
GN
| Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020 |
| 01/28/2020 |
GN
| Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial |
| 11/27/2019 |
GN
| Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference |
| 11/15/2019 |
GN
| Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference |
| 11/01/2019 |
GN
| Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019 |
| 08/29/2019 |
GN
| Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference |
| 06/24/2019 |
GN
| Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference |
| 06/19/2019 |
GN
| Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz |
| 06/14/2019 |
GN
| Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference |
| 05/31/2019 |
GN
| Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference |
| 05/10/2019 |
GN
| Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019 |
| 05/06/2019 |
GN
| Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019 |
| 03/19/2019 |
GN
| Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial |
| 02/26/2019 |
GN
| Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings |
| 01/03/2019 |
GN
| Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies |
|